Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Cox

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Virology|October 14, 2004
The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latencyJeffrey I Cohen, Edward Cox, Lesley Pesnicak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Facilitating Antibacterial Drug Development in a Time of Great NeedEdward Cox, Marco Cavaleri, Hans-Georg Eichler, et al.
Annals of Internal Medicine|December 29, 2016
The Fight Against Multidrug-Resistant BacteriaHelen W Boucher, Sara E Cosgrove, Edward Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2020
Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for GeneralizabilityStephen M Bart, John J Farley, Shukal Bala, et al.
BMC Health Services Research|June 23, 2022
The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE TrialEdward Cox, Simon Walker, Sarah Blower, et al.
Clinical Trials (London, England)|January 16, 2016
A US Food and Drug Administration perspective on evaluating medical products for EbolaEstelle Russek-Cohen, Daniel Rubin, Dionne Price, et al.
The American Journal of Bioethics : AJOB|April 10, 2015
Right job, wrong tool: a commentary on designing clinical trials for Ebola virus diseaseRobert M Nelson, Michelle Roth-Cline, Kevin Prohaska, et al.
Pharmacoeconomics|March 20, 2019
The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalEdward Cox, Ros Wade, Mathilde Peron, et al.
Sensors (Basel, Switzerland)|May 27, 2026
AI-Assisted Vision Alarming System for Blind and Vision- Impaired PeopleLe Chung Tran, Sinh Khai Ly, Rhys Blacklidge, et al.
Clinical Genitourinary Cancer|March 8, 2020
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT TrialEdward Cox, Pedro Saramago, John Kelly, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Virology|October 14, 2004
The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latencyJeffrey I Cohen, Edward Cox, Lesley Pesnicak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Facilitating Antibacterial Drug Development in a Time of Great NeedEdward Cox, Marco Cavaleri, Hans-Georg Eichler, et al.
Annals of Internal Medicine|December 29, 2016
The Fight Against Multidrug-Resistant BacteriaHelen W Boucher, Sara E Cosgrove, Edward Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2020
Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for GeneralizabilityStephen M Bart, John J Farley, Shukal Bala, et al.
BMC Health Services Research|June 23, 2022
The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE TrialEdward Cox, Simon Walker, Sarah Blower, et al.
Clinical Trials (London, England)|January 16, 2016
A US Food and Drug Administration perspective on evaluating medical products for EbolaEstelle Russek-Cohen, Daniel Rubin, Dionne Price, et al.
The American Journal of Bioethics : AJOB|April 10, 2015
Right job, wrong tool: a commentary on designing clinical trials for Ebola virus diseaseRobert M Nelson, Michelle Roth-Cline, Kevin Prohaska, et al.
Pharmacoeconomics|March 20, 2019
The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalEdward Cox, Ros Wade, Mathilde Peron, et al.
Sensors (Basel, Switzerland)|May 27, 2026
AI-Assisted Vision Alarming System for Blind and Vision- Impaired PeopleLe Chung Tran, Sinh Khai Ly, Rhys Blacklidge, et al.
Clinical Genitourinary Cancer|March 8, 2020
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT TrialEdward Cox, Pedro Saramago, John Kelly, et al.
Pageof 4